Art. 17 Regulation (EU) 2025/2086

Finalisation of the revised draft joint clinical assessment and summary reports

In forcesince 17 Oct 2025
1.

The JCA Subgroup shall discuss the revised draft joint clinical assessment and summary reports, as well as the input provided pursuant to Article 16(3) and (4), in a meeting. The JCA Subgroup, via the HTA secretariat, may invite individual experts in a dedicated part of the meeting discussing the relevant revised draft reports.

2.

The JCA Subgroup shall finalise the revised draft joint clinical assessment and summary reports within 165 days after the Commission’s confirmation that the dossier meets the requirements laid down in Article 9(2), (3) and (4) of Regulation (EU) 2021/2282. The JCA Subgroup shall submit the revised draft joint clinical assessment and summary reports to the Coordination Group for endorsement.

3.

Where the Coordination Group re-initiates a joint clinical assessment pursuant to Article 10(7) of Regulation (EU) 2021/2282, the JCA Subgroup shall finalise the revised draft joint clinical assessment and summary reports within 165 days from the date of re-initiation of the joint clinical assessment and shall submit them to the Coordination Group for endorsement.

4.

Where the Coordination Group initiates an update of a joint clinical assessment pursuant to Article 14 of Regulation (EU) 2021/2282, and provided that no update of the assessment scope is necessary, the JCA Subgroup shall finalise the revised draft joint clinical assessment and summary reports within 165 days from the Commission’s confirmation that the dossier meets the requirements laid down in Article 9(2), (3) and (4) of Regulation (EU) 2021/2282. The JCA Subgroup shall submit the revised updated draft joint clinical assessment and summary reports to the Coordination Group for endorsement.

Where the Coordination Group initiates an update of a joint clinical assessment pursuant to Article 14 of Regulation (EU) 2021/2282 and provided that an update of the assessment scope is necessary, the JCA Subgroup shall finalise the revised updated draft joint clinical assessment and summary reports within 345 days from the date on which the Coordination Group initiated the update of the joint clinical assessment. The JCA Subgroup shall submit the revised updated draft joint clinical assessment and summary reports to the Coordination Group for endorsement.

5.

The Coordination Group shall endorse the revised draft joint clinical assessment and summary reports within 30 days from their receipt, in accordance with Article 12(2) of Regulation (EU) 2021/2282.